Health

Vomiting, diarrhea and reduced intake can combine to cause dehydration during GLP-1-based treatment. Kidney injury associated with volume depletion is…

Severe or persistent abdominal pain during treatment should not be treated as ordinary adjustment. Stop the medicine and seek immediate medical advice,…

Both constipation and diarrhea can occur during GLP-1-based treatment. A change in bowel habits still deserves context: food and fluid intake, other…

With nausea after a GLP-1-based injection, the first practical question is whether you can keep fluids down. Mild queasiness and repeated vomiting are…

Prepare for a GLP-1 consultation with a medical-history and medication checklist, plus questions about pregnancy, procedures, tests and follow-up.

Understand what withdrawal research says about weight regain and how to plan follow-up, maintenance support and a safe treatment review.

Review a GLP-1 weight plateau without rushing a dose change: examine weight trend, treatment exposure, administration and changes in daily life.

Separate early appetite changes from weight trends and learn what to track during dose escalation before judging GLP-1 treatment response.

Compare Wegovy and Zepbound across seven practical criteria: mechanism, evidence, indication, tolerability, medical history, interactions and access.

Understand adult BMI thresholds, weight-related conditions and why medical eligibility, product labeling and insurance approval are different.

Learn how to distinguish common digestive symptoms from urgent warning signs and what information to give your GLP-1 prescribing team.